ACIP holds meeting to discuss vaccine updates, influenza

The U.S. Centers for Disease Control and Prevention's vaccine advisory board recently held a meeting to discuss recommendations for a variety of new vaccines.

The Advisory Committee on Immunization Practices met in Atlanta to discuss agency updates and hold a routine discussion on vaccines for pneumococcal infection, Haemophilus influenzae b, Japanese encephalitis and pertussis.

In addition to the updates, the committee will vote on recommendations for the use of PCV13 (pneumococcal conjugate vaccine) in children aged six-18 years with immune-compromising conditions, use of the Hib vaccine and coverage for both under the Vaccines for Children program for those eligible to receive the vaccine at no cost.

The committee also plans to vote on proposed influenza vaccine recommendations for the next flu season. Several researchers are scheduled to discuss various aspects of the latest flu season, including the latest surveillance and epidemiological data, vaccine supply, vaccine effectiveness and the use of FluBlok.

ACIP did not hold any media activities, but the event was streamed on the internet.

ACIP is a group of medical and public health experts that develops recommendations on how to safely and effectively use new medications to control disease in the United States. Its recommendations are non-binding, but usually followed.